M
Maritime Dermatology | Halifax, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Lebrikizumab
Upadacitinib
Dupilumab
Ruxolitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin...
Enrolling
Atopic Dermatitis
Drug: Upadacitinib
Drug: Dupilumab
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
Enrolling
NonSegmental Vitiligo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic d...
Enrolling
Atopic Dermatitis
Drug: Lebrikizumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems